Latest News
Patients Treated in COVID-19 Clinical Trial Using Stem Cells Manufactured by Performance Cell Manufacturing
Sorrento Therapeutics (Nasdaq: SRNE, "Sorrento") announced positive results from the first patients treated in its COVID-19 clinical trial using stem cells licensed from and provided by Personalized Stem Cells, Inc. (PSC). The stem cell platform and FDA approval for...
Performance Cell Manufacturing Completes Stem Cell Manufacturing Contract for Knee Osteoarthritis Clinical Trial
Performance Cell Manufacturing (PCM) recently completed a stem cell manufacturing contract for an FDA approved stem cell clinical trial for knee osteoarthritis. Manufacturing for the trial included processing adipose tissue (lipoaspirate) from 38 patients to produce...
Performance Cell Manufacturing’s Facility Approved for Stem Cell Manufacturing by the California Department of Public Health
Performance Cell Manufacturing (PCM), a contract development manufacturing organization division of VetStem Biopharma, announced that the facility they utilize for cGMP cell production is approved by the California Department of Public Health, Food and Drug Branch for...
Performance Cell Manufacturing Announces Opening of Expanded cGMP Cell Manufacturing Facility
Performance Cell Manufacturing (PCM), a division of VetStem Biopharma, announced the opening of its expanded cGMP cell therapy manufacturing facility at its headquarters in Poway, California. PCM was born from VetStem’s 15 years of experience with cGMP compliant cell...
Performance Cell Manufacturing Manufactures Stem Cells for Leading Human Cancer Therapy Company, Calidi Biotherapeutics
Performance Cell Manufacturing (PCM), a contract manufacturing organization division of VetStem Biopharma, has joined forces with leading human cancer therapy company, Calidi Biotherapeutics, to collaborate on a potential new cancer treatment. In a patented process,...